Citation 6655

FAN,W: TEZUKA,Y: KADOTA,S:. (2000). PROLYL ENDOPEPTIDASE INHIBITORY ACTIVITY OF FOURTEEN KAMPO FORMULAS AND INHIBITORY CONSTITUENTS OF TOKAKU-JOKI-TO.. 48(7)

Citation Details

TitlePROLYL ENDOPEPTIDASE INHIBITORY ACTIVITY OF FOURTEEN KAMPO FORMULAS AND INHIBITORY CONSTITUENTS OF TOKAKU-JOKI-TO.
AuthorsFAN,W: TEZUKA,Y: KADOTA,S:
Year2000
Volume48
Issue7

Summary

Year: 2000

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
PROLYL ENDOPEPTIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
LIQUIRITIGENIN-4'-O-BETA-D-GLUCOSIDEGALLIC ACIDLIQUIRITIGENIN-4'-7-DIGLUCOSIDEGALLOYLGLUCOSE,1-O:LIQUIRITIGENIN-4'-O-BETA-D-APIOFURANOSYL(1-2)-BETA-D-GLUCOPYRANOSIDELIQUIRITIGENINEMODINLINDLEYIN,ISO:LINDLEYINCINNAMIC ACIDBUTAN-2-ONE,4-(4-HYDROXY-PHENYL):CATECHIN,(+):TORACHRYSONE-8-O-BETA-D-GLUCOSIDEEMODIN-8-O-BETA-D-GLUCOSIDE
INACTIVE
2
PROLYL ENDOPEPTIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTOCATECHUIC ACID
ACTIVE
3
PROLYL ENDOPEPTIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLOYL-GLUCOSE,1-2-6-TRI-O:
ACTIVE
4
PROLYL ENDOPEPTIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
GALLIC ACID-4-O-BETA-D-(6-O-GALLOYL)-GLUCOSIDE
ACTIVE
5
PROLYL ENDOPEPTIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
LICUROSIDE
ACTIVE
6
PROLYL ENDOPEPTIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
CATECHIN,EPI: (-):
ACTIVE
7
PROLYL ENDOPEPTIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
CATECHIN,EPI: 3-O-GALLATE (-):
ACTIVE
8Not specified
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED
STILBENE,TRANS: 3-4'-5-TRIHYDROXY: 4'-O-BETA-D-GLUCOSIDE
None
9
PROLYL ENDOPEPTIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
STILBENE,TRANS: 3-4'-5-TRIHYDROXY: 4'-O-BETA-D-GLUCOSIDE
ACTIVE
10Not specified
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED
STILBENE,TRANS: 3-4'-5-TRIHYDROXY: 4'-O-BETA-D-(2-O-GALLOYL)-GLUCOSIDE
None
11
PROLYL ENDOPEPTIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
STILBENE,TRANS: 3-4'-5-TRIHYDROXY: 4'-O-BETA-D-(2-O-GALLOYL)-GLUCOSIDE
ACTIVE
12Not specified
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED
STILBENE,TRANS: 3-4'-5-TRIHYDROXY: 4'-O-BETA-D-(6-O-GALLOYL)-GLUCOSIDE
None
13
PROLYL ENDOPEPTIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
STILBENE,TRANS: 3-4'-5-TRIHYDROXY: 4'-O-BETA-D-(6-O-GALLOYL)-GLUCOSIDE
ACTIVE
14Not specified
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED
STILBENE,CIS: 3-4'-TRIHYDROXY: 4'-O-BETA-D-(6-O-GALLOYL)-GLUCOSIDE
None
15
PROLYL ENDOPEPTIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
STILBENE,CIS: 3-4'-TRIHYDROXY: 4'-O-BETA-D-(6-O-GALLOYL)-GLUCOSIDE
ACTIVE
16Not specified
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED
BUTAN-2-ONE,4-(4-HYDROXY-PHENYL):
None
17Not specified
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED
LINDLEYIN,ISO:
None
18Not specified
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED
LINDLEYIN
None
19Not specified
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED
BUTAN-2-ONE,4-(4-HYDROXY-PHENYL): 4'-O-BETA-D-(2-6-DI-O-GALLOYL)-GLUCOSIDE
None
20
PROLYL ENDOPEPTIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
BUTAN-2-ONE,4-(4-HYDROXY-PHENYL): 4'-O-BETA-D-(2-6-DI-O-GALLOYL)-GLUCOSIDE
ACTIVE
21Not specified
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED
BUTAN-2-ONE,4-(4'-HYDROXY-PHENYL): 4'-O-BETA-D-(2-O-GALLOYL-6-O-CINNAMOYL)-GLUCOSIDE
None
22
PROLYL ENDOPEPTIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
BUTAN-2-ONE,4-(4'-HYDROXY-PHENYL): 4'-O-BETA-D-(2-O-GALLOYL-6-O-CINNAMOYL)-GLUCOSIDE
ACTIVE
23Not specified
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED
BUTAN-2-ONE,4-(4'-HYDROXY-PHENYL): 4'-O-BETA-D-(2-O-CINNAMOYL-6-O-GALLOYL)-GLUCOSIDE
None
24
PROLYL ENDOPEPTIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
BUTAN-2-ONE,4-(4'-HYDROXY-PHENYL): 4'-O-BETA-D-(2-O-CINNAMOYL-6-O-GALLOYL)-GLUCOSIDE
ACTIVE
Show SPARQL Queries (1)